Clinical and Molecular Feature-Based Nomogram Model for Predicting Benefit from Bevacizumab Combined with First-Generation EGFR-tyrosine Kinase Inhibitor (TKI) in EGFR-mutant Advanced NSCLC
BMC Medicine(2021)
Key words
Clinical features,Molecular features,Prediction Model,Bevacizumab combined with EGFR-TKI,Advanced NSCLC
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined